August 28, 2008
Synergy Pharmaceuticals, a biopharma focused on gastrointestinal disorders and diseases, has appointed Melvin Spigelman to its board of directors. Additionally, Spigelman has been named chairman of Synergy's clinical oversight committee.
CommonHealth has appointed Marc Weiner as managing partner. Weiner will also remain president of both Qi and Conectics, two of the company's digital marketing arms.